Regeneron Pharmaceuticals · Purchases of Investments

Latest reported-$10.27Bperiod endingJun 30, 2026

REGN Purchases of Investments (-$137.20M → -$10.27B)

Annual purchases of investments

High-resolution chart · PNG

REGN purchases of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Purchases of Investments — Annual fiscal periods (USD)
Period ending	Purchases of Investments (USD)
Dec 31, 2025	-10,958,300,000
Dec 31, 2024	-16,617,400,000
Dec 31, 2023	-11,646,000,000
Dec 31, 2022	-7,487,900,000
Dec 31, 2021	-7,048,100,000
Dec 31, 2020	-3,241,000,000
Dec 31, 2019	-3,202,400,000
Dec 31, 2018	-1,845,500,000
Dec 31, 2017	-1,277,140,000
Dec 31, 2016	-809,419,000
Dec 31, 2015	-557,105,000
Dec 31, 2014	-564,188,000
Dec 31, 2013	-577,278,000
Dec 31, 2012	-470,393,000
Dec 31, 2011	-240,391,000
Dec 31, 2010	-612,187,000
Dec 31, 2009	-199,997,000
Dec 31, 2008	-581,139,000
Dec 31, 2007	-594,446,000
Dec 31, 2006	-456,893,000
Dec 31, 2005	-102,990,000
Dec 31, 2004	-276,318,000
Dec 31, 2003	-287,502,000
Dec 31, 2002	-239,977,000
Dec 31, 2001	-191,351,000
Dec 31, 2000	-104,898,000
Dec 31, 1999	-60,100,000
Dec 31, 1998	-88,000,000
Dec 31, 1997	-112,600,000
Dec 31, 1996	-74,600,000
Dec 31, 1995	-28,100,000
Dec 31, 1994	-22,500,000
Dec 31, 1993	-77,300,000
Dec 31, 1992	-71,600,000
Dec 31, 1991	-137,200,000